Cigna Corporation (NYSE:CI) VP Mary T. Hoeltzel sold 525 shares of the business’s stock in a transaction that occurred on Wednesday, August 9th. The stock was sold at an average price of $177.59, for a total transaction of $93,234.75. Following the sale, the vice president now directly owns 1,924 shares in the company, valued at approximately $341,683.16. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Shares of Cigna Corporation (NYSE:CI) traded down 0.56% during mid-day trading on Friday, reaching $174.38. 1,174,009 shares of the company were exchanged. The stock has a 50 day moving average price of $172.22 and a 200-day moving average price of $159.17. Cigna Corporation has a 12 month low of $115.03 and a 12 month high of $178.57. The stock has a market capitalization of $43.91 billion, a P/E ratio of 20.12 and a beta of 0.46.

Cigna Corporation (NYSE:CI) last posted its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, beating analysts’ consensus estimates of $2.48 by $0.43. Cigna Corporation had a net margin of 7.46% and a return on equity of 17.40%. The firm had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. During the same period last year, the firm posted $1.98 EPS. Cigna Corporation’s quarterly revenue was up 3.6% on a year-over-year basis. Analysts predict that Cigna Corporation will post $10.02 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Insider Selling: Cigna Corporation (NYSE:CI) VP Sells 525 Shares of Stock” was first posted by Daily Political and is the property of of Daily Political. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of U.S. & international copyright legislation. The original version of this piece can be viewed at https://www.dailypolitical.com/2017/08/11/insider-selling-cigna-corporation-nyseci-vp-sells-525-shares-of-stock.html.

A number of institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. raised its position in Cigna Corporation by 2.5% in the second quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock worth $2,867,514,000 after buying an additional 424,469 shares during the period. BlackRock Inc. raised its position in Cigna Corporation by 2,335.5% in the first quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock worth $2,488,489,000 after buying an additional 16,289,943 shares during the period. State Street Corp raised its position in Cigna Corporation by 1.7% in the first quarter. State Street Corp now owns 11,137,018 shares of the health services provider’s stock worth $1,631,451,000 after buying an additional 190,323 shares during the period. Wellington Management Group LLP raised its position in Cigna Corporation by 9.3% in the first quarter. Wellington Management Group LLP now owns 10,765,751 shares of the health services provider’s stock worth $1,577,075,000 after buying an additional 913,991 shares during the period. Finally, FMR LLC raised its position in Cigna Corporation by 6.7% in the second quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock worth $1,156,604,000 after buying an additional 432,978 shares during the period. Hedge funds and other institutional investors own 86.91% of the company’s stock.

Several analysts have weighed in on CI shares. UBS AG reissued a “buy” rating and set a $186.00 target price (up previously from $181.00) on shares of Cigna Corporation in a research report on Monday, June 5th. ValuEngine raised shares of Cigna Corporation from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Jefferies Group LLC boosted their target price on shares of Cigna Corporation from $178.00 to $183.00 and gave the stock a “buy” rating in a research report on Monday, May 15th. Deutsche Bank AG boosted their target price on shares of Cigna Corporation from $172.00 to $175.00 and gave the stock a “buy” rating in a research report on Wednesday, May 10th. Finally, Stifel Nicolaus upped their price objective on shares of Cigna Corporation from $170.00 to $175.00 and gave the company a “buy” rating in a report on Monday, May 15th. Three equities research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. Cigna Corporation has a consensus rating of “Buy” and an average price target of $180.06.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Insider Buying and Selling by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.